Story thread · 2 reports / 2 sources

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

endpts.com · 3dShare

→ As Takeda celebrates a pair of FDA approvals, one of its top execs will be retiring in June 2027. Andy Plump joined Takeda from Sanofi in 2015, and has led R&D since December 2018 ...

First report: Andy Plump, architect of Takeda’s R&D overhaul, to retire next year — biopharmadive.com, 4d